Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-003794

VP, Chief Accounting Officer gave up 227 shares (to pay taxes)

  • VP, Chief Accounting Officer acquired 552 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2021-01-13 Option exercise +552 11,811 D: show line 1 in the form
Peraza Lisa VP, Chief Accounting Officer 2021-01-13 Shares withheld for taxes −227 $18.16 $4,122 11,584 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2021-01-13 Option exercise · Restricted Stock Units −552 8,281 D: show line 3 in the form
Loading xslF345X03/doc4.xml…